News

heart drugs with stethoscope

An experimental oral PCSK9 inhibitor is associated with LDL-C reductions that could prove to be a game-changer for patient care. 

SCAI has shared a new call to action as an observance of American Heart Month. The group is asking Congress to pass new pieces of legislation that could improve care for PAD patients and get important medical devices in the hands of interventional cardiologists.

Johnson & Johnson

The voluntary action pertains to certain Cerepak Detachable Coil Systems, used to treat brain aneurysms and other neurovascular abnormalities. 

Bret Boudousquie Stratus Medical

The Magnolia, Texas, firm has seen rapid growth in recent years, being named to the Deloitte Technology Fast 500 in 2024 after logging revenue growth of 212% over a three-year period. 

congress money legislation lawmaker bill senate house senator representative

Sens. Tim Kaine, D-Va., and John Boozman, R-Ark., have introduced legislation to lift "arbitrary" caps on compensation for therapeutic and diagnostic medical physicists working in the VA. 

somatom x.ceed

Siemens self-reported a problem with software being inadvertently delivered to U.S. systems when the applications have not yet been cleared for use by the FDA. 

Testing Exam

The exam has been reworked to better reflect the challenges today’s imaging leaders face.

3T MRI for neonates approved by FDA

The MR system was designed with smaller spaces in mind, enabling installation in or very near NICUs.

merger acquisition M&A business

Backed by private equity investors at Grovecourt Capital Partners, the Florida firm is buying National Radiology Solutions for an undisclosed sum.

Stanford

Under terms of the new team-up, the two organizations plan to pioneer methods for assessing and monitoring artificial intelligence tools in medical imaging. 

Bruce Haffty, MD

A past president of the RSNA and Rutgers RO chair, Bruce Haffty, MD, will serve as the college's new chief medical officer for radiation oncology research.

Nurse

More than 75% of U.S. nurses have high hopes in generative AI’s promise for improving productivity. But less than half feel prepared to use it effectively. Never mind that almost 60% use it in their personal lives. 

Around the web

An experimental oral PCSK9 inhibitor is associated with LDL-C reductions that could prove to be a game-changer for patient care.